Protective efficacy of DNA vaccines against duck hepatitis B virus infection. - Wikidata - awgldk - TriplyDB

Protective efficacy of DNA vaccines against duck hepatitis B virus infection.

Protective efficacy of DNA vaccines against duck hepatitis B virus infection.

http://www.wikidata.org/entity/Q33781877

about

Maternally transferred antibodies from DNA-immunized avians protect offspring against hepadnavirus infection.Immunotargeting with CD154 (CD40 ligand) enhances DNA vaccine responses in ducks.IFN-gamma increases efficiency of DNA vaccine in protecting ducks against infection Entecavir therapy combined with DNA vaccination for persistent duck hepatitis B virus infection.Bicistronic woodchuck hepatitis virus core and gamma interferon DNA vaccine can protect from hepatitis but does not elicit sterilizing antiviral immunity Avian hepatitis B viruses: molecular and cellular biology, phylogenesis, and host tropism.DNA vaccine: a promising new approach for chronic hepatitis B therapy.Immunization of woodchucks with plasmids expressing woodchuck hepatitis virus (WHV) core antigen and surface antigen suppresses WHV infection.Coadministration of gamma interferon with DNA vaccine expressing woodchuck hepatitis virus (WHV) core antigen enhances the specific immune response and protects against WHV infection.Identification of antigenic regions of duck hepatitis B virus core protein with antibodies elicited by DNA immunization and chronic infection.

P2860

Q33805189-94F9B9D3-5CA5-4968-8DA4-580483AA521F Q34975067-13D1ED0C-F876-4ACE-9CFE-470E31A1A27F Q35064484-11A63A40-951F-47A2-BE5C-C31E83BD8A52 Q35166065-290A66E9-9776-415D-9F15-CD9045916EF4 Q35634911-3D2B3749-855A-4973-AB86-EBB641410CE7 Q36700708-3538C963-04E0-46A3-8757-F784926856AE Q38604885-17F71F50-8591-491E-BD00-F90DC0D5511F Q39548701-0EEA519D-ABFB-4211-9F65-8D94DB03255F Q39606099-622D169D-4401-4320-B5FB-AD20054EA047 Q40677965-529A41CB-A045-4529-8B12-35CEE59EF72D

P2860

Protective efficacy of DNA vaccines against duck hepatitis B virus infection.

http://www.wikidata.org/entity/Q33781877

description

1998 nî lūn-bûn

@nan

1998 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

1998 թվականի հունվարին հրատարակված գիտական հոդված

@hy

1998年の論文

@ja

1998年論文

@yue

1998年論文

@zh-hant

1998年論文

@zh-hk

1998年論文

@zh-mo

1998年論文

@zh-tw

1998年论文

@wuu

name

Protective efficacy of DNA vaccines against duck hepatitis B virus infection.

@ast

Protective efficacy of DNA vaccines against duck hepatitis B virus infection.

@en

type

label

Protective efficacy of DNA vaccines against duck hepatitis B virus infection.

@ast

Protective efficacy of DNA vaccines against duck hepatitis B virus infection.

@en

prefLabel

Protective efficacy of DNA vaccines against duck hepatitis B virus infection.

@ast

Protective efficacy of DNA vaccines against duck hepatitis B virus infection.

@en

P1433

Q33781877-AC3923FA-AF85-4FC8-A6D9-687721F2E7E7

P1476

Q33781877-25A13D70-2754-4852-B7E9-C7209DD92389

P2093

Q33781877-32498530-B225-4683-A988-B9DF838846CF

Q33781877-39B2A726-9886-422F-A8D2-AE4007C47A47

Q33781877-4CDCB289-C530-4CC1-B449-3CE9D13E9739

Q33781877-9DA5A05F-AB9B-4D4C-8089-6DCE8463FC27

P2860

Q33781877-0C154D96-02FC-45E2-A4C8-C63BE56A5230

Q33781877-0D595866-2FBD-47F2-A48A-2150E622C94A

Q33781877-1399B987-842B-4942-80FE-F38626AB2A12

Q33781877-1D8BB098-E855-4D68-B8DD-223E585612F5

Q33781877-35290078-D5A3-4060-8C9E-1D4AA37E1E82

Q33781877-35724302-A726-4D4D-899E-0EA55CFBAB92

Q33781877-423BFF5F-6A3C-40B2-BE61-690D5E5D2646

Q33781877-42E04033-22BA-4FB1-B4F8-071440056B57

Q33781877-4733C7E7-7367-4A51-8A12-913808909440

Q33781877-4F75D917-FD39-4FB2-875D-1B6F39E5128E

P304

Q33781877-112E0C99-D373-46E6-815A-09B9A79C860A

P31

Q33781877-9274F23C-C443-4514-BDB7-723CE40172DF

P433

Q33781877-092B3EFA-DF6A-4215-B172-78DF03DFA93A

P478

Q33781877-CD23D1D4-39FE-446D-840D-2125F34E648A

P50

Q33781877-27D8E5C4-90AA-413A-A39C-2A5F6567A5E5

P577

Q33781877-4402BF0A-B534-4BB8-8E2E-839EEC34EECA

P698

Q33781877-3078C620-2EB4-4542-8BD1-27B63506FB60

P932

Q33781877-494C659F-1F25-4418-948C-8CB63052D5DF

P1433

Journal of Virology

P1476

Protective efficacy of DNA vaccines against duck hepatitis B virus infection

@en

P2093

C J Burrell

http://www.w3.org/2001/XMLSchema#string

D S Miller

http://www.w3.org/2001/XMLSchema#string

M Qiao

http://www.w3.org/2001/XMLSchema#string

M Triyatni

http://www.w3.org/2001/XMLSchema#string

P2860

Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis

An essential G1 function for cyclin-like proteins in yeast

Urine and the laboratory diagnosis of Chlamydia trachomatis in males

Virus of Pekin ducks with structural and biological relatedness to human hepatitis B virus

CpG motifs in bacterial DNA trigger direct B-cell activation.

Immunostimulatory DNA sequences necessary for effective intradermal gene immunization.

Epitope mapping of neutralizing monoclonal antibodies against duck hepatitis B virus.

Susceptibility to duck hepatitis B virus infection is associated with the presence of cell surface receptor sites that efficiently bind viral particles.

Nucleic acid vaccination primes hepatitis B virus surface antigen-specific cytotoxic T lymphocytes in nonresponder mice.

Improvement of hepatitis B virus DNA vaccines by plasmids coexpressing hepatitis B surface antigen and interleukin-2.

P304

84-94

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

72

http://www.w3.org/2001/XMLSchema#string

P50

Allison R Jilbert

P577

1998-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

9420203

http://www.w3.org/2001/XMLSchema#string

P932

109352

http://www.w3.org/2001/XMLSchema#string